윌름스 종양 단백질 시장 : 제품 유형별, 용도별, 최종 사용자별, 검출 방법별, 병기별, 지역별
Wilms Tumor Protein Market, By Product Type, By Application, By End User, By Detection Method, By Disease Stage, By Geography
상품코드:1741106
리서치사:Coherent Market Insights
발행일:2025년 03월
페이지 정보:영문
라이선스 & 가격 (부가세 별도)
ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
한글목차
윌름스 종양 단백질 시장은 2025년에는 31억 9,000만 달러로 추정되고, 2032년에는 43억 7,000만 달러에 이를 것으로 예측되며, 2025년부터 2032년에 걸쳐 CAGR 4.6%를 나타낼 전망입니다.
보고 범위
보고서 세부정보
기준 연도
2024년
시장 규모(2025년)
31억 9,000만 달러
실적 데이터
2020-2024년
예측 기간
2025-2032년
예측 기간 : 2025-2032년 CAGR :
4.60%
가치 예측(2032년)
43억 7,000만 달러
윌름스 종양 단백질은 다양한 유형의 암 진행에 중요한 역할을 하는 전사 인자입니다. NCBI에 따르면, 윌름스 종양 단백질은 염색질 리모델링 복합체에 관여하고 다수의 유전자 발현을 촉진합니다.
시장 역학 :
세계의 암 환자 증가가 예측 기간 중의 세계의 윌름스 종양 단백질 시장 성장을 가속할 것으로 전망됩니다. 2020년 1월에 발표한 데이터에 의하면, 윌름스 종양은 소아에게 보여지는 신장암의 주류입니다. 미국에서는 매년, 500-600례의 윌름스 종양이 새롭게 보고되고 있어, 이 숫자는 장기간에 걸쳐 비교적 안정된 레벨을 나타내고 있습니다.
그러나 진단과 치료에 드는 비용이 높기 때문에 예측 기간 동안 세계의 윌름스 종양 단백질 시장의 성장이 방해받을 것으로 전망됩니다. 제한된 지역에서는 환자의 접근을 제한 할 수 있습니다.이러한 비용 장벽은 윌름 종양 단백질 관련 치료법 및 진단 방법에 대한 환자의 섭취를 감소시킬 수 있으며, 잠재적으로 시장 확대에 영향을 미치고보다 광범위한 환자 집단에 도달 할 수 있는 능력을 방해할 수 있습니다.
본 조사의 주요 특징
본 보고서에서는 세계의 윌름스 종양 단백질 시장을 상세하게 분석했으며, 2024년을 기준연도로 한 예측 기간(2025-2032년) 시장 규모 및 복합 연간 성장률(CAGR%)을 제공합니다.
또, 다양한 부문에 걸친 잠재적인 수익 기회를 해명해, 이 시장의 매력적인 투자 제안의 매트릭스에 대해서 설명하고 있습니다.
또한 시장 성장 촉진요인, 억제요인, 기회, 신제품의 상시나 승인, 시장 동향, 지역별 전망, 주요 기업이 채용하는 경쟁 전략 등에 관한 중요한 인사이트도 제공합니다.
기업 하이라이트, 제품 포트폴리오, 주요 하이라이트, 재무 실적, 전략 등의 파라미터에 근거해, 세계의 윌름스 종양 단백질 시장 주요 기업 프로파일을 제공합니다.
이 보고서로부터의 인사이트은 마케팅 담당자나 기업의 경영진이, 향후 제품 발매, 유형 업그레이드, 시장 확대, 마케팅 전술에 관한 정보에 근거한 의사 결정을 실시하는 것을 가능하게 합니다.
세계의 윌름스 종양 단백질 시장 보고서는 투자자, 공급업체, 제품 제조업체, 유통 업체, 신규 진출자, 재무 분석가 등이 업계의 다양한 이해 관계자를 대상으로 합니다.
이해관계자는 세계의 윌름스 종양 단백질 시장 분석에 사용되는 다양한 전략 매트릭스를 통해 의사결정이 용이해집니다.
목차
제1장 조사의 목적과 전제조건
조사 목적
전제조건
약어
제2장 시장 전망
보고서 설명
시장 정의 및 범위
주요 요약
일관된 기회 맵(COM)
제3장 시장 역학, 규제, 동향 분석
시장 역학
성장 촉진요인
윌름스 종양 치료에 있어서의 표적 요법 수요 증가
암 진단 및 치료 분야의 기술 개발
성장 억제요인
높은 진단과 치료 비용
기회
윌름스 종양의 조사에의 자금 제공 증가
영향 분석
주요 하이라이트
규제 시나리오
제품 출시/승인
PEST 분석
PORTER 분석
합병과 인수 시나리오
제4장 세계의 윌름스 종양 단백질 시장 - 코로나바이러스(COVID-19) 팬데믹의 영향
COVID-19 역학
공급측과 수요측의 분석
경제에 미치는 영향
제5장 세계의 윌름스 종양 단백질 시장, 제품 유형별(2020-2032년)
항체
분석 키트
유전자 재조합 단백질
기타
제6장 세계의 윌름스 종양 단백질 시장, 용도별(2020-2032년)
암 진단
암 치료
연구 및 개발
기타
제7장 세계의 윌름스 종양 단백질 시장, 최종 사용자별(2020-2032년)
병원
진단실험실
연구기관
기타
제8장 세계의 윌름스 종양 단백질 시장, 검출 방법별(2020-2032년)
면역조직화학(IHC)
효소 결합 면역 흡착 분석(ELISA)
웨스턴 블로팅
중합효소 연쇄반응(PCR)
기타
제9장 세계의 윌름스 종양 단백질 시장, 병기별(2020-2032년)
진단
모니터링 및 예후
제10장 세계의 윌름스 종양 단백질 시장, 지역별(2020-2032년)
북미
미국
캐나다
유럽
영국
독일
이탈리아
프랑스
스페인
러시아
기타 유럽
아시아태평양
중국
인도
일본
ASEAN
호주
한국
기타 아시아태평양
라틴아메리카
브라질
멕시코
아르헨티나
기타 라틴아메리카
중동
GCC
이스라엘
기타 중동
아프리카
북아프리카
중앙아프리카
남아프리카
제11장 경쟁 구도
Abcam plc.
Thermo Fisher Scientific, Inc.
Santa Cruz Biotechnology, Inc.
Novus Biologicals, LLC
R&D Systems, Inc.(a subsidiary of Bio-Techne Corporation)
OriGene Technologies, Inc.
Cell Signaling Technology, Inc.
Merck KGaA
BioLegend, Inc.
Genetex, Inc.(a subsidiary of Novus Biologicals, LLC)
Agilent Technologies, Inc.
Proteintech Group, Inc.
Sino Biological Inc.
Boster Biological Technology
Fitzgerald Industries International
제12장 섹션
조사 방법
출판사에 대해
KTH
영문 목차
영문목차
Wilms Tumor Protein Market is estimated to be valued at USD 3.19 Bn in 2025 and is expected to reach USD 4.37 Bn by 2032, growing at a compound annual growth rate (CAGR) of 4.6% from 2025 to 2032.
Report Coverage
Report Details
Base Year:
2024
Market Size in 2025:
USD 3.19 Bn
Historical Data for:
2020 To 2024
Forecast Period:
2025 To 2032
Forecast Period 2025 to 2032 CAGR:
4.60%
2032 Value Projection:
USD 4.37 Bn
Wilms tumor protein is a transcription factor that plays an important role in the progression of various types of cancer. It has also been shown to be associated with resistance to chemotherapies. As a result, Wilms tumor protein has been proposed to be a promising target for the development of new anti-cancer drugs. According to NCBI, Wilms tumor protein is involved in the chromatin remodeling complex and promotes the expression of several genes. It has been shown to interact with several chemotherapeutic agents including daunorubicin and mitoxantrone.
Market Dynamics:
Increasing cancer cases worldwide is expected to drive growth of the global wilms tumor protein market over the forecast period. Moreover, increasing awareness regarding Wilms tumor and its treatment and diagnosis is also expected to propel growth of the global Wilms tumor protein market over the forecast period. According to the data published by American Cancer Society in January 2020, Wilms tumor stands as the predominant form of kidney cancer found in children. Annually, in the U.S., 500 to 600 new Wilms tumor cases are reported, a figure that has exhibited relatively consistent levels over an extended period. Wilms tumors account for approximately 5% of all childhood cancer cases.
However, high cost of diagnosis and treatment procedures is expected to hinder growth of the global Wilms tumor protein market over the forecast period. The high cost of diagnosis and treatment procedures can significantly hinder the growth of the global Wilms tumor protein market. Expensive diagnostic tests and treatments may limit accessibility for patients, particularly in regions with limited healthcare resources. This cost barrier could reduce patient uptake of Wilms tumor protein-related therapies and diagnostics, potentially impacting the market's expansion and inhibiting the ability to reach a broader patient population.
Key features of the study:
This report provides in-depth analysis of the global wilms tumor protein market, and provides market size (US$ Bn) and compound annual growth rate (CAGR%) for the forecast period (2025-2032), considering 2024 as the base year
It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
It profiles key players in the global wilms tumor protein market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
Key companies covered as a part of this study include Abcam plc, Thermo Fisher Scientific, Inc., Santa Cruz Biotechnology, Inc., Novus Biologicals, LLC, R&D Systems, Inc. (a subsidiary of Bio-Techne Corporation), OriGene Technologies, Inc., Cell Signaling Technology, Inc., Merck KGaA, BioLegend, Inc., Genetex, Inc. (a subsidiary of Novus Biologicals, LLC), Agilent Technologies, Inc., Proteintech Group, Inc., Sino Biological Inc., Boster Biological Technology, and Fitzgerald Industries International
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
Global wilms tumor protein market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global wilms tumor protein market
Global Wilms Tumor Protein Market Detailed Segmentation:
By Product Type:
Antibodies
Assay Kits
Recombinant Proteins
Others
By Application:
Cancer Diagnosis
Cancer Treatment
Research and Development
Others
By End User:
Hospitals
Diagnostic Laboratories
Research Institutes
Others
By Detection Method:
Immunohistochemistry (IHC)
Enzyme-Linked Immunosorbent Assay (ELISA)
Western Blotting
Polymerase Chain Reaction (PCR)
Others
By Disease Stage:
Diagnosis
Monitoring and Prognosis
By Region:
North America
Europe
Asia Pacific
Latin America
Middle East
Africa
Company Profiles:
Abcam plc
Thermo Fisher Scientific, Inc.
Santa Cruz Biotechnology, Inc.
Novus Biologicals, LLC
R&D Systems, Inc. (a subsidiary of Bio-Techne Corporation)
OriGene Technologies, Inc.
Cell Signaling Technology, Inc.
Merck KGaA
BioLegend, Inc.
Genetex, Inc. (a subsidiary of Novus Biologicals, LLC)
Agilent Technologies, Inc.
Proteintech Group, Inc.
Sino Biological Inc.
Boster Biological Technology
Fitzgerald Industries International
Table of Contents
1. Research Objectives and Assumptions
Research Objectives
Assumptions
Abbreviations
2. Market Purview
Report Description
Market Definition and Scope
Executive Summary
Market Wilms Tumor Protein, By Product Type
Market Wilms Tumor Protein, By Application
Market Wilms Tumor Protein, By End User
Market Wilms Tumor Protein, By Detection Method
Market Wilms Tumor Protein, By Disease Stage
Market Wilms Tumor Protein, By Region
Coherent Opportunity Map (COM)
3. Market Dynamics, Regulations, and Trends Analysis
Market Dynamics
Drivers
Increasing demand for targeted therapies for Wilms tumor treatment
Technological developments in the field of cancer diagnostics and treatment
Restraints
High cost of diagnosis and treatment procedures
Opportunities
Growing funding for research on Wilms tumor
Impact Analysis
Key Highlights
Regulatory Scenario
Product Launches/Approvals
PEST Analysis
PORTER's Analysis
Merger and Acquisition Scenario
4. Global Wilms Tumor Protein Market- Impact of Coronavirus (COVID-19) Pandemic
COVID-19 Epidemiology
Supply Side and Demand Side Analysis
Economic Impact
5. Global Wilms Tumor Protein Market, By Product Type, 2020-2032, (US$ Bn)
Introduction
Market Share Analysis, 2025 and 2032 (%)
Y-o-Y Growth Analysis, 2021 - 2032
Segment Trends
Antibodies
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Bn)
Assay Kits
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Bn)
Recombinant Proteins
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Bn)
Others
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Bn)
6. Global Wilms Tumor Protein Market, By Application, 2020-2032, (US$ Bn)
Introduction
Market Share Analysis, 2025 and 2032 (%)
Y-o-Y Growth Analysis, 2021 - 2032
Segment Trends
Cancer Diagnosis
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Bn)
Cancer Treatment
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Bn)
Research and Development
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Bn)
Others
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
7. Global Wilms Tumor Protein Market, By End User, 2020-2032, (US$ Bn)
Introduction
Market Share Analysis, 2025 and 2032 (%)
Y-o-Y Growth Analysis, 2021 - 2032
Segment Trends
Hospitals
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Bn)
Diagnostic Laboratories
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Bn)
Research Institutes
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Bn)
Others
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Bn)
8. Global Wilms Tumor Protein Market, By Detection Method, 2020-2032, (US$ Bn)
Introduction
Market Share Analysis, 2025 and 2032 (%)
Y-o-Y Growth Analysis, 2021 - 2032
Segment Trends
Immunohistochemistry (IHC)
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2020-2032,( US$ Bn)
Enzyme-Linked Immunosorbent Assay (ELISA)
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Bn)
Western Blotting
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Bn)
Polymerase Chain Reaction (PCR)
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Bn)
Others
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Bn)
9. Global Wilms Tumor Protein Market, By Disease Stage, 2020-2032, (US$ Bn)
Introduction
Market Share Analysis, 2025 and 2032 (%)
Y-o-Y Growth Analysis, 2021 - 2032
Segment Trends
Diagnosis
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Bn)
Monitoring and Prognosis
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Bn)
10. Global Wilms Tumor Protein Market, By Region, 2020-2032, (US$ Bn)
Introduction
Market Share Analysis, By Region, 2025 and 2032 (%)
Y-o-Y Growth Analysis, For Region, 2025-2032
Country Trends
North America
Introduction
Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2020-2032, (US$ Bn)
Market Size and Forecast, and Y-o-Y Growth, By Application, 2020-2032,(US$ Bn)
Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2032,(US$ Bn)
Market Size and Forecast, and Y-o-Y Growth, By Detection Method, 2020-2032, (US$ Bn)
Market Size and Forecast, and Y-o-Y Growth, By Disease Stage, 2020-2032, (US$ Bn)
Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032, (US$ Bn)
U.S.
Canada
Europe
Introduction
Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2020-2032, (US$ Bn)
Market Size and Forecast, and Y-o-Y Growth, By Application, 2020-2032, (US$ Bn)
Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2032, (US$ Bn)
Market Size and Forecast, and Y-o-Y Growth, By Detection Method, 2020-2032, (US$ Bn)
Market Size and Forecast, and Y-o-Y Growth, By Disease Stage, 2020-2032, (US$ Bn)
Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032, (US$ Bn)
U.K.
Germany
Italy
France
Spain
Russia
Rest of Europe
Asia Pacific
Introduction
Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2020-2032, (US$ Bn)
Market Size and Forecast, and Y-o-Y Growth, By Application, 2020-2032, (US$ Bn)
Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2032, (US$ Bn)
Market Size and Forecast, and Y-o-Y Growth, By Detection Method, 2020-2032, (US$ Bn)
Market Size and Forecast, and Y-o-Y Growth, By Disease Stage, 2020-2032, (US$ Bn)
Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032, (US$ Bn)
China
India
Japan
ASEAN
Australia
South Korea
Rest of Asia Pacific
Latin America
Introduction
Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2020-2032, (US$ Bn)
Market Size and Forecast, and Y-o-Y Growth, By Application, 2020-2032, (US$ Bn)
Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2032, (US$ Bn)
Market Size and Forecast, and Y-o-Y Growth, By Detection Method, 2020-2032, (US$ Bn)
Market Size and Forecast, and Y-o-Y Growth, By Disease Stage, 2020-2032, (US$ Bn)
Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032, (US$ Bn)
Brazil
Mexico
Argentina
Rest of Latin America
Middle East
Introduction
Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2020-2032, (US$ Bn)
Market Size and Forecast, and Y-o-Y Growth, By Application, 2020-2032, (US$ Bn)
Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2032, (US$ Bn)
Market Size and Forecast, and Y-o-Y Growth, By Detection Method, 2020-2032, (US$ Bn)
Market Size and Forecast, and Y-o-Y Growth, By Disease Stage, 2020-2032, (US$ Bn)
Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032, (US$ Bn)
GCC
Israel
Rest of Middle East
Africa
Introduction
Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2020-2032, (US$ Bn)
Market Size and Forecast, and Y-o-Y Growth, By Application, 2020-2032, (US$ Bn)
Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2032, (US$ Bn)
Market Size and Forecast, and Y-o-Y Growth, By Detection Method, 2020-2032, (US$ Bn)
Market Size and Forecast, and Y-o-Y Growth, By Disease Stage, 2020-2032, (US$ Bn)
Market Size and Forecast, and Y-o-Y Growth, By Country/Sub-Region, 2020-2032, (US$ Bn)
North Africa
Central Africa
South Africa
11. Competitive Landscape
Abcam plc.
Company Highlights
Product Portfolio
Key Developments
Financial Performance
Strategies
Thermo Fisher Scientific, Inc.
Company Highlights
Product Portfolio
Key Highlights
Financial Performance
Strategies
Santa Cruz Biotechnology, Inc.
Company Highlights
Product Portfolio
Key Highlights
Financial Performance
Strategies
Novus Biologicals, LLC
Company Highlights
Product Portfolio
Key Highlights
Financial Performance
Strategies
R&D Systems, Inc. (a subsidiary of Bio-Techne Corporation)
Company Highlights
Product Portfolio
Key Highlights
Financial Performance
Strategies
OriGene Technologies, Inc.
Company Highlights
Product Portfolio
Key Highlights
Financial Performance
Strategies
Cell Signaling Technology, Inc.
Company Highlights
Product Portfolio
Key Highlights
Financial Performance
Strategies
Merck KGaA
Company Highlights
Product Portfolio
Key Highlights
Financial Performance
Strategies
BioLegend, Inc.
Company Highlights
Product Portfolio
Key Highlights
Financial Performance
Strategies
Genetex, Inc. (a subsidiary of Novus Biologicals, LLC)
